CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...

The system that has driven life-altering discoveries and helped make the United States a superpower is now under intense ...

When the beloved science publication got too political, its corporate owners stepped in. Now its future is uncertain. In ...

Fintel reports that on October 29, 2026, Jefferies downgraded their outlook for Boston Scientific (NYSE:BSX) (BMV:BSX) from Buy to Hold. This rating action follows a prior action by Jefferies on June ...

Through the Young Researchers Institute Fellowship, students are learning how AI can expand access to scientific research, ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Eurofins Scientific updated its 2026 guidance after weaker than usual market conditions and cancelled clinical programmes, ...

EVERSANA has acquired Estima Scientific, a London-based health economics and outcomes research technology and services ...

Fintel reports that on 30 October 2026, TD Cowen downgraded their outlook for Boston Scientific (LSE:0HOY) from Buy to Hold.

Boston Scientific (BSX) stock falls as the company, with its Q3 2026 results, cuts its outlook, citing impact from a recent ...

It’s vital to “keep humans in the loop” to avoid humanizing machine-learning models in research One big risk is less obvious, though potentially very consequential: humans tend to attribute a great ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...